Cefoxitin
Sponsors
The University Of Queensland, Centre Hospitalier Universitaire De Toulouse, Assistance Publique - Hôpitaux de Paris, Central Hospital, Nancy, France, Poitiers University Hospital
Conditions
Acute Pyelonephritis Without Severity Symptoms Due to ESBL-producing E.ColiAntibiotic Prophylaxis SurgeryAppendicitis (Diagnosis)Maternal Infection During Pregnancy (Diagnosis)Mycobacterium Abscessus InfectionMycobacterium Abscessus Pulmonary DiseaseMycobacterium abscessus pulmonary diseaseNeonatal Infection
Phase 1
Phase 2
Finding the Optimal Regimen for Mycobacterium Abscessus Treatment
RecruitingNCT04310930
Start: 2020-03-02End: 2030-06-30Target: 300Updated: 2025-08-13
Finding the Optimal Regimen for Mycobacterium abscessus Treatment
RecruitingCTIS2023-506575-99-00
Start: 2023-01-02Target: 20Updated: 2025-10-13
Testing a Novel Combination Treatment (Arm D) Versus Standard of Care for Intensive Phase Treatment for Mycobacterium Abscessus Pulmonary Disease in People With or Without Cystic Fibrosis in the Finding the Optimal Regimen for Mycobacterium Abscessus Treatment (FORMaT) Adaptive Platform Trial
Not yet recruitingNCT07485010
Start: 2027-04-01End: 2031-07-01Target: 300Updated: 2026-03-20
Phase 3
Does Cefoxitin or Piperacillin-Tazobactam Prevent Postoperative Surgical Site Infections After Pancreatoduodenectomy?
CompletedNCT03269994
Start: 2017-11-21End: 2025-01-28Updated: 2025-10-21
Efficacy of non operative treatment with amoxicillin/clavulanic acid versus surgical treatment in acute uncomplicated appendicitis in children: a prospective multicenter randomized controlled non-inferiority trial with cost utility analysis
Not yet recruitingCTIS2024-519402-12-00
Target: 724Updated: 2025-10-17
Phase 4
Evaluation of the Non-inferiority of Cefoxitin Versus Imipenem/Cilastatin in the Treatment of Urinary Tract Infections Caused by ESBL-producing Escherichia Coli
TerminatedNCT02474706
Start: 2016-03-31End: 2017-12-31Updated: 2017-08-11
Study of Repeated Cefoxitin Administration in Major Abdominal Surgery Using a Microdialysis Technique
CompletedNCT02703857
Start: 2016-02-29End: 2016-09-20Updated: 2017-06-12
Unknown Phase
Efficacy and Pharmacokinetic/Pharmacodynamic Parameters of Cefoxitin in Women With Acute Pyelonephritis Without Severity Symptoms Due to Extended-spectrum β-lactamase Producing Escherichia Coli
TerminatedNCT01820793
Start: 2013-05-31End: 2015-11-30Updated: 2018-01-12
Immediate Versus Delayed Induction in Term-PROM Using or Not Antibiotic Prophylaxis
NCT02985086
Start: 2013-07-31End: 2018-07-31Target: 568Updated: 2016-12-13